Target intelligence / Profile preview

microRNA-23c (miR-23c)

Target
miR-23c
Molecular classification
MicroRNA, Small non-coding RNA, Other
01

Overview

microRNA-23c (miR-23c) is a member of the microRNA family, a class of small non-coding RNAs (typically 19–25 nucleotides) that regulate gene expression primarily by binding to complementary sequences in the 3′ untranslated regions (3′-UTRs) of target messenger RNAs (mRNAs), resulting in translational repression or mRNA degradation[3]. miR-23c shares its seed sequence with miR-23a-3p and miR-23b-3p, forming part of the same microRNA family[1]. Recent studies have identified significant downregulation of miR-23c expression during prostate cancer progression, particularly in bone metastases compared to localized prostate cancer and benign tissue. Forced overexpression of miR-23c in prostate cancer cell lines reduces cell proliferation in vitro, suggesting tumor suppressor-like properties, though in vivo evidence for tumor suppression is limited[1]. The expression and functional effects of miR-23c in other tissues and disease contexts remain less characterized.

Other names
miR-23cMIR23Chsa-miR-23chsa-mir-23cmir-23c
02

Mechanism of action

Not established for drugs; microRNA-23c acts through post-transcriptional repression of mRNA targets

03

Biological functions

Regulation of gene expressionCell proliferationCell differentiationApoptosisPossible tumor suppression
04

Disease associations

Cancer (notably prostate cancer)
05

Biomarkers

Downregulation in prostate cancer progression (potential biomarker for advanced disease)

Beyond the preview

Go deeper on microRNA-23c (miR-23c).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA-23c (miR-23c).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call